Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Evolent Health, Inc.EVH · Entity 5492 | Chief Financial Officer | March 01, 2019 | March 05, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Evolent Health, Inc.
Report date March 01, 2019 · Filed March 05, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 84,088 |
Reported balance
After 2019-03-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2019-03-01 · Grant · Acquired 30,098 · Balance 84,088 F1: Represents restricted stock units granted to Mr. McGrane pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2: Securities vest at a rate of 25% annually beginning March 1, 2020. F3: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| Class A Common Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.29 · Expires 2029-03-01 | Direct | 57,741 |
Reported balance
After 2019-03-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-03-01 · Grant · Acquired 57,741 · Balance 57,741 F4: Securities vest at a rate of 25% annually beginning March 1, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units granted to Mr. McGrane pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2: Securities vest at a rate of 25% annually beginning March 1, 2020.
F3: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F4: Securities vest at a rate of 25% annually beginning March 1, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2019 Filed Mar 5, 2019 16:50 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock Option (right to buy) · Derivative | 57,741 | $0.00 Strike: $13.29 | $0.00 |
DisclosureSEC source: 0001628908-19-000010 · primary_doc.xml · derivative · entry 2 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,741 Underlying: Class A Common Stock · 57,741 shares Expires 2029-03-01 F4 · derivative.exercise_date: Securities vest at a rate of 25% annually beginning March 1, 2020. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 16:50 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 30,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-19-000010 · primary_doc.xml · nonDerivative · entry 1 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,088 F1 · security: Represents restricted stock units granted to Mr. McGrane pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest at a rate of 25% annually beginning March 1, 2020. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 17:13 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock Option (right to buy) · Derivative | 52,609 | $0.00 Strike: $13.95 | $0.00 |
DisclosureSEC source: 0001628908-18-000005 · primary_doc.xml · derivative · entry 2 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,609 Underlying: Class A Common Stock · 52,609 shares Expires 2028-02-01 F4 · derivative.exercise_date: Securities vest at a rate of 25% annually beginning February 1, 2019. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 17:13 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 22,401 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-18-000005 · primary_doc.xml · nonDerivative · entry 1 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,990 F1 · security: Represents restricted stock units granted to Mr. McGrane pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest at a rate of 25% annually beginning February 1, 2019. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 17:14 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock Option (right to buy) · Derivative | 1,667 | $0.00 Strike: $3.84 | $0.00 |
DisclosureSEC source: 0001628908-17-000036 · primary_doc.xml · derivative · entry 3 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,618 Underlying: Class A Common Stock · 1,667 shares Expires 2024-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on September 14, 2016. F4 · derivative.exercise_date: The Class A Common Stock Options exercised vested on February 1, 2016. Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 17:14 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 1,667 | $25.42 | $42,375.14 |
DisclosureSEC source: 0001628908-17-000036 · primary_doc.xml · nonDerivative · entry 2 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,589 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on September 14, 2016. F3 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $25.25-$25.55, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 17:14 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock | 1,667 | $3.84 | $6,401.28 |
DisclosureSEC source: 0001628908-17-000036 · primary_doc.xml · nonDerivative · entry 1 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on September 14, 2016. F2 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 17:32 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock Option (right to buy) · Derivative | 1,667 | $0.00 Strike: $3.84 | $0.00 |
DisclosureSEC source: 0001628908-17-000032 · primary_doc.xml · derivative · entry 4 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,285 Underlying: Class A Common Stock · 1,667 shares Expires 2024-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F4 · derivative.exercise_date: The Class A Common Stock Options exercised vested on February 1, 2016. Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 17:32 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 100 | $25.40 | $2,540.00 |
DisclosureSEC source: 0001628908-17-000032 · primary_doc.xml · nonDerivative · entry 3 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,589 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 17:32 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 1,567 | $24.53 | $38,438.51 |
DisclosureSEC source: 0001628908-17-000032 · primary_doc.xml · nonDerivative · entry 2 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,689 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F3 · price: The price reported on Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.05-$24.85, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 17:32 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock | 1,667 | $3.84 | $6,401.28 |
DisclosureSEC source: 0001628908-17-000032 · primary_doc.xml · nonDerivative · entry 1 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 07, 2017 Filed Jun 8, 2017 16:38 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $3.84 | $0.00 |
DisclosureSEC source: 0001643086-17-000004 · primary_doc.xml · derivative · entry 4 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,952 Underlying: Class A Common Stock · 10,000 shares Expires 2024-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F4 · derivative.exercise_date: The Class A Common Stock Options exercised vested on February 1, 2016. Read SEC document |
| June 07, 2017 Filed Jun 8, 2017 16:38 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 10,000 | $27.01 | $270,100.00 |
DisclosureSEC source: 0001643086-17-000004 · primary_doc.xml · nonDerivative · entry 3 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,589 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F3 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $27.00-$27.025, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 07, 2017 Filed Jun 8, 2017 16:38 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock | 10,000 | $3.84 | $38,400.00 |
DisclosureSEC source: 0001643086-17-000004 · primary_doc.xml · nonDerivative · entry 2 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,589 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 06, 2017 Filed Jun 8, 2017 16:38 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 495 | $25.75 | $12,746.25 |
DisclosureSEC source: 0001643086-17-000004 · primary_doc.xml · nonDerivative · entry 1 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,589 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| May 19, 2017 Filed May 23, 2017 18:21 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock Option (right to buy) · Derivative | 47,508 | $0.00 Strike: $3.84 | $0.00 |
DisclosureSEC source: 0000950157-17-000719 · form4.xml · derivative · entry 3 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,952 Underlying: Class A Common Stock · 47,508 shares Expires 2024-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Class A Common Stock Options exercised vested on November 1, 2015. Read SEC document |
| May 19, 2017 Filed May 23, 2017 18:21 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 47,508 | $24.30 | $1,154,444.40 |
DisclosureSEC source: 0000950157-17-000719 · form4.xml · nonDerivative · entry 2 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,084 F1 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| May 19, 2017 Filed May 23, 2017 18:21 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock | 47,508 | $3.84 | $182,430.72 |
DisclosureSEC source: 0000950157-17-000719 · form4.xml · nonDerivative · entry 1 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| May 10, 2017 Filed May 12, 2017 18:45 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock Option (right to buy) · Derivative | 1,667 | $0.00 Strike: $3.84 | $0.00 |
DisclosureSEC source: 0001643086-17-000003 · primary_doc.xml · derivative · entry 3 McGrane Nicholas · CIK 0001643086 · Cheif Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,460 Underlying: Class A Common Stock · 1,667 shares Expires 2024-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F3 · derivative.exercise_date: The Class A Common Stock exercised vested on November 1, 2015. One fourth of the Class A Common Stock Options granted to the reporting person on October 22, 2014 vested on November 1, 2015; the balance vested or vests at a rate of 6.25% as of the end of each three-month period immediately thereafter during the period beginning on October 23, 2015, the day following the first anniversary of the grant date. Read SEC document |
| May 10, 2017 Filed May 12, 2017 18:45 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 1,667 | $24.28 | $40,474.76 |
DisclosureSEC source: 0001643086-17-000003 · primary_doc.xml · nonDerivative · entry 2 McGrane Nicholas · CIK 0001643086 · Cheif Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,380 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The shares were sold in multiple transactions at prices ranging from $23.90-$24.65, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2017 Filed May 12, 2017 18:45 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock | 1,667 | $3.84 | $6,401.28 |
DisclosureSEC source: 0001643086-17-000003 · primary_doc.xml · nonDerivative · entry 1 McGrane Nicholas · CIK 0001643086 · Cheif Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 16:26 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock Option (right to buy) · Derivative | 1,667 | $0.00 Strike: $3.84 | $0.00 |
DisclosureSEC source: 0001643086-17-000002 · primary_doc.xml · derivative · entry 3 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,127 Underlying: Class A Common Stock · 1,667 shares Expires 2024-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F3 · derivative.exercise_date: The Class A Common Stock Options exercised vested on November 1, 2015. One fourth of the Class A Common Stock Options granted to the reporting person on October 22, 2014 vested on November 1, 2015; the balance vested or vests at a rate of 6.25% as of the end of each three-month period immediately thereafter during the period beginning on October 23, 2015, the day following the first anniversary of the grant date. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 16:26 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 1,667 | $22.52 | $37,540.84 |
DisclosureSEC source: 0001643086-17-000002 · primary_doc.xml · nonDerivative · entry 2 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,380 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The shares were sold in multiple transactions at prices ranging from $22.50-22.525, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 16:26 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock | 1,667 | $3.84 | $6,401.28 |
DisclosureSEC source: 0001643086-17-000002 · primary_doc.xml · nonDerivative · entry 1 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| March 24, 2017 Filed Mar 27, 2017 17:11 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock Option (right to buy) · Derivative | 5,001 | $0.00 Strike: $3.84 | $0.00 |
DisclosureSEC source: 0001643086-17-000001 · primary_doc.xml · derivative · entry 4 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,794 Underlying: Class A Common Stock · 5,001 shares Expires 2024-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F3 · derivative.exercise_date: The Class A Common Stock Options exercised vested on November 1, 2015. One fourth of the Class A Common Stock Options granted to the reporting person on October 22, 2014 vested on November 1, 2015; the balance vested or vests at a rate of 6.25% as of the end of each three-month period immediately thereafter during the period beginning on the day following the first anniversary of the grant date. Read SEC document |
| March 24, 2017 Filed Mar 27, 2017 17:11 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 2,033 | $22.50 | $45,742.50 |
DisclosureSEC source: 0001643086-17-000001 · primary_doc.xml · nonDerivative · entry 3 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,380 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| March 24, 2017 Filed Mar 27, 2017 17:11 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClsss A Common Stock | 5,001 | $22.50 | $112,522.50 |
DisclosureSEC source: 0001643086-17-000001 · primary_doc.xml · nonDerivative · entry 2 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,413 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The shares were sold in a multiple transactions, all at a price of $22.50. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction covered by this footnote. Read SEC document |
| March 24, 2017 Filed Mar 27, 2017 17:11 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock | 5,001 | $3.84 | $19,203.84 |
DisclosureSEC source: 0001643086-17-000001 · primary_doc.xml · nonDerivative · entry 1 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 19:37 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock Option (right to buy) · Derivative | 38,297 | $0.00 Strike: $18.25 | $0.00 |
DisclosureSEC source: 0000950157-17-000198 · form4.xml · derivative · entry 2 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,297 Underlying: Class A Common Stock · 38,297 shares Expires 2027-02-01 F3 · derivative.exercise_date: Securities vest at a rate of 25% annually beginning February 1, 2018. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 19:37 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 17,123 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-17-000198 · form4.xml · nonDerivative · entry 1 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,413 F1 · security: Represents restricted stock units granted to Mr. McGrane pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation plan. F2 · shares: Securities vest at a rate of 25% annually beginning February 1, 2018. Read SEC document |
| September 14, 2016 Filed Sep 15, 2016 16:48 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock Option (right to buy) · Derivative | 21,205 | $0.00 Strike: $3.84 | $0.00 |
DisclosureSEC source: 0000950157-16-002176 · form4.xml · derivative · entry 3 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,795 Underlying: Class A Common Stock · 21,205 shares Expires 2024-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Class A Common Stock Options exercised vested on November 1, 2015. One fourth of the Class A Common Stock Options granted to the reporting person on October 22, 2014 vested on November 1, 2015; the balance vested or vests at a rate of 6.25% as of the end of each three-month period immediately thereafter during the period beginning on the day following the first anniversary of the grant date. Read SEC document |
| September 14, 2016 Filed Sep 15, 2016 16:48 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 21,205 | $21.54 | $456,755.70 |
DisclosureSEC source: 0000950157-16-002176 · form4.xml · nonDerivative · entry 2 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,290 F1 · price: The price of $21.54 represents the public offering price of $22.50 per share of Class A Common Stock less the underwriters' discount of $0.96 per share. Read SEC document |
| September 14, 2016 Filed Sep 15, 2016 16:48 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock | 21,205 | $3.84 | $81,427.20 |
DisclosureSEC source: 0000950157-16-002176 · form4.xml · nonDerivative · entry 1 McGrane Nicholas · CIK 0001643086 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,495 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.